Author

William M. Carroll

Observed names: W.M. Carroll, William M. Carroll MBBS, MD, FRACP, FRCP(E), William-M. Carroll

Institutions: The University of Western Australia, Perron Institute for Neurological and Translational Science

Observed institutions: The University of Western Australia, Ollscoil na Gaillimhe – University of Galway, Sir Charles Gairdner Hospital, Perron Institute for Neurological and Translational Science

ORCID: 0000-0002-5088-548X

Observed ORCID: 0000-0002-5088-548X

OpenAlex ID: A5005966031

Global gene expression analysis of the effects of vinblastine on endothelial cells, when eluted from a thermo‐responsive polymer

2006 · E. McLucas, H. Gallagher, et al. · Journal of Biomedical Materials Research Part A · 4

Faible activité de la maladie après un traitement de 4 ans par ocrelizumab (OCR) chez des patients naïfs de traitement atteints de sclérose en plaques récurrente-rémittente (SEP-RR) à un stade précoce ; données de l’étude de phase IIIb ensemble

2024 · Bruno Brochet, Francesco Patti, et al. · Revue Neurologique

2009 · Robert P. Lisak MD, FAAN, FRCP, Daniel D. Truong MD, FAAN, et al.

2009 · Robert P. Lisak MD, FAAN, FRCP, Daniel D. Truong MD, FAAN, et al.

Works count: 4

Citation count: 4

H-index: 1

I10-index: